RKLB

Rocket Lab USA
D

RKLB

Rocket Lab USA executives and insider trading

Sir Peter Beck reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Rocket Lab USA's insiders sold 8,822,697 shares for 661.31M USD in 203 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
203
Shares sold
8,822,697
Value sold
661.31M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
7.98M USD
0
3 months
34.94M USD
0
6 months
367.81M USD
0
1 year
661.31M USD
0
2 years
1.07B USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Peter Beck Director, CEO—5,813,493429.59M USD—8 Jul 20262,449,223
Adam Spice Chief Financial Officer & Treasurer571,933,902138.59M USD—2 Nov 20261,296,124
Frank Klein Chief Operations Officer53345,87825.92M USD—27 Aug 2026945,995
Alexander R Slusky Director—200,00025.72M USD—2 Jun 2026334,675
Arjun L. Kampani Senior Vice President, General Counsel & Corporate Secretary54217,23319.27M USD—27 Aug 2026252,351
Merline Saintil Director—161,62612.85M USD—6 Mar 2026261,903
Jon A Olson Director—90,6055.13M USD—20 Jan 2026348,112
Nina Armagno Director—38,2402.44M USD—2 Nov 2026107,396
Marvin Bradford Clevenger President of Rocket Lab USA Inc.—18,5511.56M USD—24 Aug 2026460,051
Edward H. Frank Director—2,500193.47K USD—23 Dec 202591,373
Agostino Ricupati VP, Corporate Controller & Chief Accounting Officer5966946.58K USD—24 Aug 202626,913

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
2 Nov 2026Nina ArmagnoSale4,02651.31206.57K USD107,396Form 4
2 Nov 2026Nina ArmagnoSale1,50052.6378.95K USD105,896Form 4
2 Nov 2026Nina ArmagnoSale3,00053.55160.66K USD102,896Form 4
2 Nov 2026Nina ArmagnoSale2,30054.34124.97K USD100,596Form 4
2 Nov 2026Nina ArmagnoSale10055.015.50K USD100,496Form 4
2 Nov 2026Adam SpiceSale47,55451.282.44M USD1,248,570Form 4
2 Nov 2026Adam SpiceSale14,26652.26745.60K USD1,234,304Form 4
2 Nov 2026Adam SpiceSale33,68153.291.79M USD1,200,623Form 4
2 Nov 2026Adam SpiceSale37,95054.072.05M USD1,162,673Form 4
2 Nov 2026Adam SpiceSale6,70654.78367.39K USD1,155,967Form 4
1 Oct 2026Adam SpiceSale39,66970.282.79M USD1,256,455Form 4
1 Oct 2026Adam SpiceSale85,28870.896.05M USD1,171,167Form 4
1 Oct 2026Adam SpiceSale15,20071.791.09M USD1,155,967Form 4
2 Sept 2026Adam SpiceSale67,25762.264.19M USD1,228,867Form 4
2 Sept 2026Adam SpiceSale72,90062.974.59M USD1,155,967Form 4

Common questions about Rocket Lab USA's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.